FluoretiQ, which is part of the Deepbridge Life Sciences EIS portfolio, as of February 21st 2022, has announced the completion of a £1.1 million, pre-series A investment. The funding round was led by Deepbridge Capital, with significant participation from MAINStream, OION, SAIC and existing investors.
Deepbridge Capital has been shortlisted for the Deal of the Year (Transaction size below £2.5 million) Award at the upcoming 2022 Insider Media, Northern Ireland Dealmakers Awards.
Hy-genie, a portfolio company within the Deepbridge Life Sciences EIS fund, was a worthy winner of Business Cloud's MedTech 50 innovation ranking last year - with the help from Alder Hey Children's Hospital in its progress.
